financetom
Business
financetom
/
Business
/
BRIEF-Kayne Anderson Bdc, Inc. Announces Proposed Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Kayne Anderson Bdc, Inc. Announces Proposed Initial Public Offering
May 13, 2024 4:59 AM

May 13 (Reuters) -

* KAYNE ANDERSON BDC, INC.: ANNOUNCES PROPOSED INITIAL

PUBLIC

OFFERING

* KAYNE ANDERSON BDC, INC: PLANS TO MAKE IPO OF 6 MILLION

SHARES

OF COMMON STOCK WITH IPO PRICE EXPECTED TO BE $16.63 PER SHARE

Source text for Eikon:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Global-e Q1: Sales Up 30%, GMV Soars 34%, Extends Strategic Partnership With Shopify
Global-e Q1: Sales Up 30%, GMV Soars 34%, Extends Strategic Partnership With Shopify
May 26, 2025
Global-E Online Ltd. shares are trading lower after the company reported its first-quarter FY25 results. Sales grew 30% year over year (Y/Y) to $189.9 million, beating the analyst consensus estimate of $187.87 million. Gross Merchandise Value (GMV) rose 34% Y/Y to $1.24 billion in the quarter. The company reported $84.0 million in service fees and $105.9 million in fulfillment services revenue in the quarter. Non-GAAP gross profit increased to $86.3 million (+31% Y/Y), and non-GAAP gross margin expanded 10 basis points Y/Y...
--Empower Enlists Apollo, Franklin Templeton, Goldman to Provide Private Assets in Retirement Accounts
--Empower Enlists Apollo, Franklin Templeton, Goldman to Provide Private Assets in Retirement Accounts
May 26, 2025
10:50 AM EDT, 05/14/2025 (MT Newswires) -- Price: 145.16, Change: +0.09, Percent Change: +0.06 ...
Novo Nordisk, Septerna Strike $2.2 Billion Deal to Develop, Commercialize Obesity, Diabetes Treatments
Novo Nordisk, Septerna Strike $2.2 Billion Deal to Develop, Commercialize Obesity, Diabetes Treatments
May 26, 2025
10:54 AM EDT, 05/14/2025 (MT Newswires) -- Novo Nordisk ( NVO ) on Wednesday entered into a global collaboration and licensing agreement with Septerna ( SEPN ) to develop and commercialize medicines for obesity, type 2 diabetes, and other cardiometabolic diseases. California-based Septerna ( SEPN ) will be eligible to receive about $2.2 billion in upfront and milestone payments from...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved